Rnaseh2atm1(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Rnaseh2atm1(KOMP)Wtsi |
Name: |
ribonuclease H2, large subunit; targeted mutation 1, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4362394 |
Gene: |
Rnaseh2a Location: Chr8:85683239-85694498 bp, - strand Genetic Position: Chr8, 41.38 cM, cytoband C3
|
IMPC: |
Rnaseh2a gene page |
|
Mutant Cell Lines: |
EPD0311_2_A08, EPD0311_2_C07, EPD0311_2_C09, EPD0311_2_C10, EPD0311_2_C11, EPD0311_2_D03, EPD0311_2_D05, EPD0311_2_D06, EPD0311_2_D09, EPD0311_2_E09, EPD0311_2_E11, EPD0311_2_F06, EPD0311_2_G03, EPD0311_2_G04, EPD0311_2_H08, EPD0311_2_H10 |
Germline Transmission: |
Unknown
|
Parent Cell Line: |
JM8A1.N3 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The insertion of the L1L2_Bact_P cassette created a deletion of size 1390 starting at position 85691722 and ending at position 85693112 of Chromosome 8 (Genome Build GRCm39). This deletion results in the removal of functionally critical exon(s). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site.
(J:148605, J:173534)
|
|
|
|
|
Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
All: |
3 reference(s) |
|